In a study presented today at the Alzheimer’s Association International Conference 2016, researchers at the Douglas Mental Health University Institute have explored how some people may develop the hallmarks of Alzheimer’s or Parkinson’s but never develop symptoms. Alzheimer’s is typified by the build-up of amyloid protein in the brain, and Parkinson’s disease by the loss of a key chemical messenger in the brain called dopamine. However, it’s becoming clear that individuals can exhibit these changes but show no changes in their memory, thinking or day-to-day function. Using brain imaging data from large-scale studies into both diseases, the team identified regions of the brain associated with resilience to these changes, such as a key region in the memory centre of the brain which was preserved despite the build-up of amyloid. By mapping these potential protective networks in the brain, the researchers hope to identify potential new approaches to treat the disease as well as ways to indicate those most at risk.
Author Archives: Robin Brisbourne
Innovative project reduces antipsychotic drug use in dementia care home
In research presented today at the Alzheimer’s Association International Conference 2016, a team based in New South Wales, Australia, has shown how non-drug approaches to manage behavioural symptoms can reduce the use of antipsychotic drugs.
Occupational complexity linked to better cognitive performance after damage to the brain’s white matter
Researchers in the US have presented findings indicating that individuals who have a history of complex occupations, involving work with other people, are better able to maintain memory and thinking skills in the presence of specific brain changes associated with Alzheimer’s disease.
Genetic and non-genetic resilience against memory decline and Alzheimer’s
Researchers across the world are keen to understand why some people experience memory decline or diseases like Alzheimer’s, while others don’t. At AAIC2016, two teams of researchers are presenting findings revealing clues to genetic and non-genetic factors influencing a person’s resilience to memory decline and Alzheimer’s.
Alzheimer’s researchers investigate diabetes link in mice
Researchers in Aberdeen have highlighted a possible new link between Alzheimer’s disease and diabetes according to a new study published today in the journal Diabetologia.
Loss of Y chromosome in blood cells linked to higher Alzheimer’s risk in men
A new study involving over 3,200 people has found that older men with a loss of the Y chromosome in some blood cells may be more likely to develop Alzheimer’s disease. The research is published on Tuesday 24 May in the American Journal of Human Genetics.
Study links high blood pressure and risk of dementia
Researchers analysing the health records of over 4 million people in the UK have confirmed a previously-reported link between high blood pressure and the risk of vascular dementia– the second most common cause of dementia after Alzheimer’s disease. The study is published today (Wednesday) in the journal Stroke.
UCL reception marks launch of Drug Discovery Institute
Today saw an important event in the evolution of the Alzheimer’s Research UK Drug Discovery Alliance with a London reception to mark the launch of the UCL Drug Discovery Institute. Part of a network of three Institutes, the UCL Drug Discovery Institute will work with its counterparts at the Universities of Oxford and Cambridge to support the translation of cutting-edge academic science towards new treatments for dementia. The event, hosted by UCL and Alzheimer’s Research UK, saw several speakers take to the stage to discuss current efforts in dementia research at the university and reflect on the importance of the charity’s investment.
Diabetes drug could influence brain activity in Alzheimer’s
Researchers in Denmark have released findings from a small clinical trial of the diabetes drug liraglutide in people living with Alzheimer’s disease.
Mouse study sheds new light on memory loss in Alzheimer’s
US researchers have used a genetic technique in mice to reveal that early memory problems in Alzheimer’s are likely to be caused by difficulties retrieving memories, rather than laying down new ones. The research highlights particular cells in the brain that could be responsible for retrieving memories, which could be targeted by future treatments against the disease. The findings are published on 16 March in the journal Nature.